Association between neonatal morbidities and head growth from birth until discharge in very-low-birthweight infants

Rivka H Regev1,2, Shmuel Arnon3,4, Ita Litmanovitz3,4

  • 1Department of Neonatology, Meir Hospital, Sapir Medical Center, Kfar Saba, Israel. regevdr@netvision.net.il.

Insights

Major neonatal morbidities are linked to poor head growth in preterm very-low-birthweight infants. Understanding this association is key to improving head development and outcomes for these vulnerable newborns.

Area of Science:

  • Neonatalogy
  • Pediatric Neurology
  • Developmental Pediatrics

Background:

  • Preterm birth is associated with significant neonatal morbidities.
  • Head growth is a critical indicator of neurodevelopment in infants.
  • Very-low-birthweight (VLBW) infants are particularly vulnerable to growth disturbances.

Purpose of the Study:

  • To investigate the association between major neonatal morbidities and head growth failure (HGF) in preterm VLBW infants.
  • To quantify the risk of HGF in relation to specific neonatal complications.

Main Methods:

  • A population-based observational study included 12,992 preterm infants (24-32 weeks gestation, birthweight ≤1500g).
  • Head growth failure was defined by a decrease in head circumference z-score (>2 for severe, 1-2 for moderate).
  • Multinomial logistic regression analysis identified morbidities associated with HGF.

Main Results:

  • Severe HGF occurred in 4.5% and moderate HGF in 20.9% of infants.
  • Increased odds of HGF were associated with respiratory distress syndrome, bronchopulmonary dysplasia, necrotizing enterocolitis, and sepsis.
  • Each unit increase in head circumference z-score at birth was linked to significantly higher odds of both severe and moderate HGF.

Conclusions:

  • Major neonatal morbidities are significantly associated with head growth failure in preterm VLBW infants.
  • Further research is needed to determine if morbidities directly cause HGF or if it's mediated by nutritional/growth factors.
  • Identifying the mechanisms underlying HGF can lead to targeted interventions to improve head growth in this population.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.7K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
47.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K